The world’s largest society for radiation oncology professionals recently voted to grant David Raben, MD, the designation of American Society for Radiation Oncology Fellow (FASTRO). Raben will receive the designation at an awards ceremony on Tuesday, October 23, during ASTRO’s 60th Annual Meeting in San Antonio.
“Dr. Raben joins an elite group of physicians and medical physicists who are recognized for their far-reaching contributions to the field of radiation oncology and their progress in advancing cancer research, education and patient care,” said Brian Kavanagh, MD, MPH, FASTRO, Chair of the ASTRO Board of Directors and investigator at the University of Colorado Cancer Center.
Raben’s career focus is translational radiation oncology research with expertise in head and neck, lung and GU cancers. He attended Duke University for undergraduate studies (1981-1985), Wake Forest School of Medicine (1990-1995) and his radiation oncology training was completed at the Johns Hopkins Hospital in 1994. He, along with his twin brother, were motivated to follow in his father’s footsteps, Dr. Milton Raben, former chairman of Radiation Oncology at Wake Forest University, when they saw how he impacted the lives of his patients and meshed biology, physics and clinical care for a rewarding career.
“It is an honor to be in such distinguished company,” says Raben. “The University of Colorado Cancer Center has a wonderful spirit of collaboration and it truly allowed me to think out of the box in radiation oncology over these past 20 years. I look forward to finding more ways to offer innovative treatments. Radiation oncology, a targeted therapy in its own right, in the future will be an important tool to enable and promote options like immunotherapy to help cure cancers in the advanced setting safely so cancer survivors live longer lives with better quality of life.”
Awarded annually since 2006, the ASTRO Fellows program recognizes individuals who have made significant contributions to radiation oncology through research, education, patient care and/or service to the field. Since its inception, the FASTRO designation has been awarded to just 327 of ASTRO’s more than 10,000 members worldwide; the 2018 class of Fellows comprises 35 individuals, including Dr. Raben. Dr. Raben has been a faculty member in the Department of Radiation Oncology at the University of Colorado since 1998.